Elucid

Boston, United States Founded: 2013 • Age: 13 yrs
AI-based arterial analysis software is developed for clinical providers.

About Elucid

Elucid is a Healthcare company based in Boston (United States) founded in 2013 by James Hamilton and Andrew J Buckler. AI-based arterial analysis software is developed for clinical providers. Elucid has raised $206.87 million across 8 funding rounds from investors including Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners. Its chief executive, as recorded, is Blake Richards. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ELUCID BIOIMAGING INC. Its competitors include Vista.ai and Dyad Medical; 1 of its 2 listed competitors has raised funding.

Company details

Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.

  • Headquarters Boston, United States
  • Founders James Hamilton, Andrew J Buckler
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website elucid.com
  • Social LinkedIn X YouTube
  • Legal Name Elucid Bioimaging Inc.
Key Metrics

Apps and channels of Elucid

its YouTube channel Elucid has 86 subscribers and 30 videos.

Elucid
YouTube 86 subscribers 30 videos Science & Technology
Open channel

Videos from Elucid

The most watched videos on Elucid's YouTube channel, Elucid (86 subscribers). Click a video to play it here.

Elucid's Company Culture
446 views
Elucid at SCCT 2024: Precision Cardiovascular Pathways with Histology-based Plaque Quantitation
263 views
Webinar: Dr. Maros Ferencik and Dr. Todd Villines on the newest plaque analysis technology using CT
188 views
Webinar: Dr. Sarah Rinehart and Dr. Todd Villines on the newest plaque analysis technology using CT
136 views

More on Elucid.

Funding Insights of Elucid

Elucid has successfully raised a total of $206.87M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $55 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $206.87M
  • Total Rounds 8
  • Last Round Series D β€” $55M
  • First Round $375,000

    (Aug 2013)

  • Investors Count 9

All 8 funding rounds of Elucid with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2026$55MSeries D––
Oct 2025$36.5MSeries C––
–
Oct 2023$80MSeries C–Elevage Medical Technologies
–
Jun 2022$27MSeries B––
May 2021$8MSeries A––
Sep 2015$4.57MGrant––
Apr 2014$1.35MGrant––
Aug 2013$375,000Seed––
–
Valuation history

9 investors in total: 9 institutional.

Investors in Elucid

Elucid has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
medtexventures.com
Venture capital investments are provided by IAG Capital Partners.
iagcapitalpartners.comCharleston, USA
bluestonevp.com
Biovision Ventures is focused on investing in life sciences and healthcare innovations.
biovision.vcLuxembourg, Luxembourg
Bold Brain Capital is focused on AI healthcare investments.
boldbrain.vcDurham, United States
elevagemedical.com
Elevage Medical Technologies is focused on supporting medtech innovation.
elevagemedicaltechnologies.comAustin, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Venture capital investments are made in early-stage healthcare startups.
globalhealthimpactfund.comSan Ramon, USA
Premium access

Investor details for Elucid

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Elucid

13 people are tracked at Elucid (7 in leadership, 6 in team).

NameRoleGroup
James Hamilton
Co-FounderLeadership
Andrew J Buckler
Co-Founder & PresidentLeadership
Blake Richards
CEOLeadership
John Sukumar Aluru
Director Clinical Development- ImagingLeadership
Shruti Choudhary M.D., Ms
Senior Vice President, ProductLeadership
Windi Hary
Chief Regulatory And Quality OfficerLeadership
Ruby Gill
VP Of ProductLeadership
Lalitha Kosuri
Manager, Software Quality AssuranceTeam
David Smith
Senior Program ManagerTeam
Vivian Zhang, MPH
Marketing ManagerTeam
Amy Kruglak, SPHR
SVP Of People & Leadership DevelopmentTeam
Divya Inamdar
Product OwnerTeam
Svetlana Napris
SQA EngineerTeam
Premium access

Complete people profiles for Elucid

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Elucid

3 dated milestones of Elucid across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Elucid is founded.
  2. Funding First funding round of $375K.
  3. Funding Latest funding round, Series D, of $55.0M.

Competitors of Elucid

Elucid has 2 listed competitors in our database, 1 of them funded. They include Vista.ai and Dyad Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vista.ai2012Palo Alto, United States$8.7M13
AI-guided software is utilized to automate MRI exams for clinicians.
dyadmed.com2016Boston, United States
AI-based automated interpretation of medical images is provided.
Premium access

Detailed competitors of Elucid

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Elucid

The website of Elucid (elucid.com) receives about 5.6K visits a month.

  • Monthly visits
    5.6K

    ▲ 23.9% vs previous month

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as Elucid (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Elucid

Premium access

Complete news archive for Elucid

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elucid

Elucid was founded in 2013.

Elucid is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Blake Richards is the CEO of Elucid, as recorded in our data.

Elucid is a funded company, having raised a total of $206.87M across 8 funding rounds to date. The company's 1st funding round was a Seed of $375K, raised on Aug 2013.

Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.

Elucid's top competitors include Vista.ai and Dyad Medical.

Elucid has 9 investors. Key investors include Elevage Medical Technologies, MedTex Ventures, IAG Capital Partners, BlueStone Venture Partners, and Biovision Ventures.

Elucid operates through Elucid Bioimaging Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available